SS Innovations International Inc(SSII) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -0.06 | Insider Own | 80.37% | Shs Outstand | 200.2M | Perf Week | 1.24% |
| Market Cap | 0.49B | Forward P/E | - | EPS next Y | - | Insider Trans | -0.02% | Shs Float | 39.4M | Perf Month | -15.57% |
| Enterprise Value | 0.48B | PEG | - | EPS next Q | -0.01 | Inst Own | 0.93% | Short Float | 0.18% | Perf Quarter | -38.85% |
| Income | -0.01B | P/S | 9.35 | EPS this Y | - | Inst Trans | -2.27% | Short Ratio | 1.21 | Perf Half Y | -41.77% |
| Sales | 0.05B | P/B | 9.15 | EPS next 5Y | 44.97% | ROA | -14.89% | Short Interest | 0.07M | Perf YTD | -57.04% |
| Book/sh | 0.27 | P/C | 21.94 | EPS past 3/5Y | 36.64% 33.24% | ROE | -26.06% | 52W High | -73.05% ($9.05) | Perf Year | -71.36% |
| Cash/sh | 0.11 | P/FCF | - | Sales past 3/5Y | 209.1% - | ROIC | -22.22% | 52W Low | 10.91% ($2.20) | Perf 3Y | -75.58% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -0.32% | Gross Margin | 45.14% | Volatility(W/M) | 11% 9.25% | Perf 5Y | 87.69% |
| Dividend TTM | - | EV/Sales | 9.26 | Sales Y/Y TTM | 89.98% | Oper. Margin | -16.24% | ATR (14) | 0.22 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.66 | EPS Q/Q | -923.08% | Profit Margin | -23.76% | RSI (14) | 39 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.24 | Sales Q/Q | 39.48% | SMA20 | -4.7% ($2.56) | Beta | -110.15 | Target Price | $7 |
| Payout | - | Debt/Eq | 0.33 | Earnings | 2026/8/13 | SMA50 | -18.89% ($3.01) | Rel Volume | 0.24 | Prev Close | $2.5 |
| Employees | 483 | LT Debt/Eq | 0.05 | EPS/Sales Surpr. | - 16.16% | SMA200 | -37.65% ($3.91) | Avg Volume(3M) | 0.06M | Price | $2.44 |
| IPO | 2018/10/17 | Option/Short | No/Yes | Trades | 258 | Volume | 13,539 | Change | -2.4% |
🤖 SS Innovations International (SSII) is a commercial-stage surgical robotics company that develops and manufactures its own SSi Mantra surgical robotic system. Headquartered in India, the company is expanding its installed base into Southeast Asia, the Middle East, South America, and other regions, while also supplying robotic surgical platforms along with dedicated endoscopic surgical instruments, mixed-reality training, and multimedia recording solutions.
Over the past 1 year, on the lower side
73% below its 1-year high.
Traded less than usual. That is 24% of its average volume.
SSII has a sound balance sheet but weak earning power
Of every $100 in sales, $16.24 is lost.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +0.0% this year.
Tap to view numbers
Relative to sales, it looks expensive
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $935. Peers typically go for $343.
Tap to view numbers
Not enough quarters to judge yet
Only 1 quarter(s) reported, so no grade yet.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have paid off
Bought 5 years ago, your return today would be +87.7%. The S&P 500 did +69% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 0.9%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #59 of 142 in the industry
Based on market cap of $489M.
FAQ
What kind of company is SSII?
SSII belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of SSII?
The market cap of SSII is approximately $489M, ranking 3,181 within its sector.
What is the 52-week high and low for SSII?
SSII has recorded a 52-week high of $9.05 and a low of $2.20.